First Washington Corp’s Neuronetics STIM Stock Holding History

First Washington Corp’s Portfolio STIM Stock Details STIM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-1,274,540	Closed	-$2.29M	–	61
2024 Q2	$2.29M	Buy	1,274,540 +599,455	+89%	+$1.73M	0.85%	40
2024 Q1	$3.21M	Buy	675,085 +204,402	+43%	+$718K	1.23%	33
2023 Q4	$1.36M	Sell	470,683 -40,513	-8%	-$63.9K	0.52%	48
2023 Q3	$690K	Buy	511,196 +14,851	+3%	+$26K	0.28%	54
2023 Q2	$1.07M	Hold	496,345	–	–	0.47%	48
2023 Q1	$1.44M	Hold	496,345	–	–	0.71%	45
2022 Q4	$3.41M	Buy	496,345 +35,967	+8%	+$170K	1.67%	31
2022 Q3	$1.46M	Hold	460,378	–	–	0.74%	52
2022 Q2	$1.48M	Sell	460,378 -2,196	-0.5%	-$6.38K	0.69%	49
2022 Q1	$1.4M	Buy	462,574 +7,138	+2%	+$24.1K	0.57%	49
2021 Q4	$2.03M	Sell	455,436 -5,873	-1%	-$28.8K	0.79%	44
2021 Q3	$3.03M	Buy	461,309 +237,907	+106%	+$2.28M	1.1%	46
2021 Q2	$3.58M	Hold	223,402	–	–	1.33%	40
2021 Q1	$2.76M	Buy	+223,402	New	+$3.42M	1.09%	45

Other funds holding STIM

KLP

Kent Lake PR Anasco, Puerto Rico $198M AUM 5.21% 1-Year Est. Return

Cannell Capital Alta, Wyoming $163M AUM 40.62% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

MCM

Masters Capital Management Atlanta, Georgia $3.03B AUM 57.21% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

FCM

FourWorld Capital Management New York $196M AUM 42.39% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

DCM

DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

First Washington Corp's STIM Position: Q3 2024 in Review

First Washington Corp sold out of Neuronetics (STIM) in Q3 2024, closing a stake of 1,274,540 shares — an estimated $2.29M sold.

First Washington Corp first reported a position in STIM in Q1 2021 and held it in 14 quarters. The position peaked at $3.58M in Q2 2021. 48 funds tracked by Wall St. Rank hold STIM as of Q3 2024.

First Washington Corp reported no remaining Neuronetics position as of Q3 2024 after selling out during the quarter.
First Washington Corp sold 1,274,540 Neuronetics shares in Q3 2024, an estimated $2.29M.
First Washington Corp first reported a position in Neuronetics in Q1 2021 and held it in 14 quarters.
First Washington Corp's Neuronetics position peaked at $3.58M in Q2 2021.
48 funds tracked by Wall St. Rank held Neuronetics as of Q3 2024.

Based on First Washington Corp's 13F filing for Q3 2024, filed 13 Nov 2024.